| Autor: |
Volf EM; Tufts University School of Medicine, Boston, MA 02111, USA. eva.volf@tufts.edu, Levine DE, Michelon MA, Au SC, Patvardhan E, Dumont N, Loo DS, Kuvin J, Gottlieb AB |
| Jazyk: |
angličtina |
| Zdroj: |
Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2011 Aug; Vol. 10 (8), pp. 900-1. |
| Abstrakt: |
Adult patients with psoriasis have an increased prevalence of the metabolic syndrome (MetS) and cardiovascular disease (CVD) risk factors due to elevations of Tumor Necrosis Factor and other inflammatory cytokines.1,2 Recently, higher rates of hyperlipidemia, obesity, hypertension, and diabetes mellitus were seen in patients with juvenile psoriasis.3 Here, we report the interim results of an ongoing study of MetS and CVD risk factors in pediatric psoriasis patients. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
